Common use of Drug Testing Methodology Clause in Contracts

Drug Testing Methodology. 1. The testing or processing phase shall consist of a two- step procedure: a. initial screening test b. confirmation test 2. The urine sample is first tested using the initial drug screening procedure. An initial positive test result will not be considered conclusive; rather, it will be classified as "confirmation pending." Notification of test results to the supervisor or other departmental designee shall be held until the confirmation test results are obtained and verified by the M.R.O. 3. A specimen testing positive will undergo an additional confirmatory test. The confirmation procedure shall be technologically different and more sensitive than the initial screening test. 4. The drug screening tests selected shall be capable of identifying marijuana, cocaine and every major drug of abuse including heroin, amphetamines and barbiturates. Personnel utilized for testing will be qualified to collect urine samples, or adequately trained in collection procedures. 5. Concentrations of a drug at or about the following levels shall be considered a positive test result when using the initial immunoassay drug screening test: Initial Test Level (ng/ ml) Marijuana metabolite 100 Cocaine metabolite 300 Opiate metabolite 300* Phencyclidine 25 Amphetamines 1000 Barbiturates 300 *25ng/ml if immunoassay-specific for free morphine. Concentrations of a drug at or above the following levels shall be considered a positive test result when performing a confirmatory CG/MS test on a urine specimen that tested positive using a technologically different test than the initial screening method: Confirmatory Test Level Marijuana metabolite 15* Cocaine metabolite 150** Opiates: Morphine 300+ Codeine 300+ Phencyclidine ▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ 500 Methamphetamine 500 * Delta-9-tetrahydrocannabinol-9-carboxylic acid ** Benzoylecgonine + 25ng/ ml if immunoassay-specific for free morphine Barbiturates 300 6. The laboratory selected to conduct the analysis shall be experienced and capable of quality control, documentation, chain-of-custody, technical expertise and demonstrated proficiency in urinalysis. 7. Employees having negative drug test results shall receive a memorandum stating that no illegal drugs were found. A copy of the letter will be placed in the Employee's personnel file upon the Employee's request. 8. Any employee who interferes with the testing process or breaches the confidentiality of test results shall be subject to discipline.

Drug Testing Methodology. 1. The testing or processing phase shall consist of a two- two-step procedure: a. initial Initial screening test b. confirmation Confirmation test 2. The urine sample is first tested using the initial drug screening procedure. An initial positive test result will not be considered conclusive; rather, it will be classified as "“confirmation pending." ”. Notification of test results to the supervisor or other departmental designee shall be held until the confirmation Confirmation test results are obtained and verified by the M.R.O.obtained. 3. A specimen testing positive will undergo an additional confirmatory test. The confirmation procedure shall be technologically different and more sensitive than the initial screening test. 4. The drug screening tests selected shall be capable of identifying marijuana, cocaine and every major drug of abuse including heroin, amphetamines and barbiturates. Personnel utilized for testing will be certified as qualified to collect urine samples, samples or adequately trained in collection procedures. 5. Concentrations of a drug at or about above the following levels shall be considered a positive test result when using the initial a FPIA immunoassay drug screening test: Initial Test Level (ng/ ml) Marijuana metabolite Amphetamines 500 ng/1 Barbiturates 500 ng/1 Cocaine 300 ng/1 Opiates 300 ng/1 THC 100 Cocaine metabolite 300 Opiate metabolite 300* Phencyclidine ng/1 PCP 25 Amphetamines 1000 Barbiturates 300 *25ng/ml if immunoassay-specific for free morphine. Concentrations ng/1 Benzodiazepines 200 ng/1 Methadone 25 ng/1 Concentration of a drug at or above the following levels shall be considered a positive test result when performing a confirmatory CGGC/MS test on a urine specimen that tested positive using a technologically different test than the initial screening method: Confirmatory Test Level . Marijuana metabolite 15* Cocaine metabolite 150150 ** Opiates: Morphine 300+ 300 *** Codeine 300+ 300 Phencyclidine ▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ 25 Amphetamines: Amphetamine 500 Methamphetamine 500 * Delta-9-Delta-9 tetrahydrocannabinol-9-carboxylic acid ** Benzoylecgonine + 25ng/ *** 25ng/ml if immunoassay-specific for free morphine Barbiturates 300morphine 6. The laboratory selected to conduct the analysis shall be experienced and capable of quality control, documentation, chain-of-custody, technical expertise expertise, and demonstrated proficiency in urinalysis. 7. Employees Officers having negative drug test results shall receive a memorandum stating that no illegal drugs were found. A If the officer requests such, a copy of the letter will be placed in the Employee's officer’s personnel file upon the Employee's requestfile. 8. Any employee officer who interferes with the testing process or breaches the confidentiality of test results testing information shall be subject to discipline.

Drug Testing Methodology. 1. The testing or processing phase shall consist of a two- two-step procedure: a. initial Initial screening test b. confirmation Confirmation test 2. The urine sample is first tested using the initial drug screening procedure. An initial positive test result will not be considered conclusive; rather, it will be classified as "confirmation pending." ". Notification of test results to the supervisor or other departmental designee shall be held until the confirmation Confirmation test results are obtained and verified by the M.R.O.obtained. 3. A specimen testing positive will undergo an additional confirmatory test. The confirmation procedure shall be technologically different and more sensitive than the initial screening test. 4. The drug screening tests selected shall be capable of identifying marijuana, cocaine and every major drug of abuse including heroin, amphetamines and barbiturates. Personnel utilized for testing will be certified as qualified to collect urine samples, samples or adequately trained in collection procedures. 5. Concentrations of a drug at or about above the following levels shall be considered a positive test result when using the initial a FPIA immunoassay drug screening test: Initial Test Level (ng/ ml) Marijuana metabolite 100 Cocaine metabolite 300 Opiate metabolite 300* Phencyclidine 25 Amphetamines 1000 ng/1 Barbiturates 500 ng/1 Cocaine 300 *25ng/ml if immunoassay-specific for free morphine. Concentrations ng/1 Opiates 300 ng/1 THC 100 ng/1 PCP 25 ng/1 Benzodiazepines 300 ng/1 Methadone 25 ng/1 Concentration of a drug at or above the following levels shall be considered a positive test result when performing a confirmatory CGGC/MS test on a urine specimen that tested positive using a technologically different test than the initial screening method: Confirmatory Test Level . Marijuana metabolite 1515 * Cocaine metabolite 150150 ** Opiates: Morphine 300+ 300 *** Codeine 300+ 300 Phencyclidine ▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ 25 Amphetamines: Amphetamine 500 Methamphetamine 500 * Delta-9-Delta-9 tetrahydrocannabinol-9-carboxylic acid ** Benzoylecgonine + 25ng/ *** 25ng/ml if immunoassay-specific for free morphine Barbiturates 300morphine 6. The laboratory selected to conduct the analysis shall be experienced and capable of quality control, documentation, chain-of-custody, technical expertise expertise, and demonstrated proficiency in urinalysis. 7. Employees having negative drug test results shall receive a memorandum stating that no illegal drugs were found. A If the employee requests such, a copy of the letter will be placed in the Employeetheemployee's personnel file upon the Employee's requestfile. 8. Any employee who interferes with the testing process or breaches the confidentiality of test results shall be subject to discipline.

Drug Testing Methodology. 1. The testing or processing phase shall consist of a two- two-step procedure: a. initial screening test b. confirmation test 2. The urine sample is first tested using the initial drug screening procedure. An initial positive test result will not be considered conclusive; rather, it will be classified as "confirmation pending." Notification of test results to the supervisor or other departmental designee shall be held until the confirmation test results are obtained and verified by the M.R.O. 3. A specimen testing positive will undergo an additional confirmatory test. The confirmation procedure shall be technologically different and more sensitive than the initial screening test. 4. The drug screening tests selected shall be capable of identifying marijuanamarihuana, cocaine and every major drug of abuse including heroin, amphetamines and barbiturates. Personnel utilized for testing will be qualified to collect urine samples, or adequately trained in collection procedures. 5. Concentrations of a drug at or about the following levels shall be considered a positive test result when using the initial immunoassay drug screening test: Initial Test Level (ng/ ng/ml) Marijuana Marihuana metabolite 100 Cocaine metabolite 300 Opiate metabolite 300* Phencyclidine 25 Amphetamines 1000 Barbiturates 300 *25ng25 ng/ml if immunoassay-specific for free morphine. Concentrations of a drug at or above the following levels shall be considered a positive test result when performing a confirmatory CG/MS test on a urine specimen that tested positive using a technologically different test than the initial screening method: Confirmatory Test Level Marijuana Marihuana metabolite 15* Cocaine metabolite 150** Opiates: Morphine 300+ Codeine 300+ Phencyclidine 25 Amphetamines : Amphetamine ▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ *▇▇▇▇▇ 500 Methamphetamine 500 * Delta-9-9-tetrahydrocannabinol-9-carboxylic acid ** *Benzoylecgonine + 25ng/ 25 ng/ml if immunoassay-specific for free morphine Barbiturates 300 6. The laboratory selected to conduct the analysis shall be experienced and capable of quality control, documentation, chain-of-custody, technical expertise and demonstrated proficiency in urinalysis. 7. Employees having negative drug test results shall receive a memorandum stating that no illegal drugs were found. A copy of the letter will be placed in the Employee's personnel file upon the Employee's request. 8. Any employee who interferes with the testing process or breaches the confidentiality of test results shall be subject to discipline.

Drug Testing Methodology. 1. The testing or processing phase shall consist of a two- two-step procedure: a. initial screening test b. confirmation test 2. The urine sample is first tested using the initial drug screening procedure. An initial positive test result will not be considered conclusive; rather, it will be classified as "“confirmation pending." ” Notification of test results to the supervisor or other departmental designee shall be held until the confirmation test results are obtained and verified by the M.R.O. 3. A specimen testing positive will undergo an additional confirmatory test. The confirmation procedure shall be technologically different and more sensitive than the initial screening test. 4. The drug screening tests selected shall be capable of identifying marijuana, cocaine and every major drug of abuse including heroin, amphetamines and barbiturates. Personnel utilized for testing will be qualified to collect urine samples, or adequately trained in collection procedures. 5. Concentrations of a drug at or about the following levels shall be considered a positive test result when using the initial immunoassay drug screening test: Initial Test Level (ng/ ml) Marijuana metabolite 100 Cocaine metabolite 300 Opiate metabolite 300300 * Phencyclidine 25 Amphetamines 1000 Barbiturates 300 *25ng/ml if immunoassay-specific for free morphine. Concentrations of a drug at or above the following levels shall be considered a positive test result when performing a confirmatory CG/MS test on a urine specimen that tested positive using a technologically different test than the initial screening method: Confirmatory Test Level Marijuana metabolite 1515 * Cocaine metabolite 150150 ** Opiates: Morphine 300300 + Codeine 300300 + Phencyclidine ▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ 25 Amphetamines Amphetamine 500 Methamphetamine 500 * Delta-9-tetrahydrocannabinol-9-carboxylic acid ** *Benzoylecgonine + 25ng/ 25ng/ml if immunoassay-specific for free morphine Barbiturates 300 6. The laboratory selected to conduct the analysis shall be experienced and capable of quality control, documentation, chain-of-custody, technical expertise and demonstrated proficiency in urinalysis. 7. Employees having negative drug test results shall receive a memorandum stating that no illegal drugs were found. A copy of the letter will be placed in the Employee's ’s personnel file upon the Employee's ’s request. 8. Any employee who interferes with the testing process or breaches the confidentiality of test results shall be subject to discipline.

Drug Testing Methodology. 1. The testing or processing phase shall consist of a two- two-step procedure: a. initial Initial screening test, and b. confirmation Confirmation test. 2. The urine sample is first tested using the initial drug screening procedure. An initial positive test result will not be considered conclusive; rather, it will be classified as "confirmation pending." Notification of test results to the supervisor or other departmental designee shall be held until the confirmation test results are obtained and verified by the M.R.O.obtained. 3. A specimen specimen-testing positive will undergo an additional confirmatory test. The confirmation procedure shall be technologically different and more sensitive than the initial screening test. 4. The drug screening tests selected shall be capable of identifying marijuana, cocaine cocaine, and every major drug of abuse including heroin, amphetamines amphetamine and barbiturates. Personnel utilized for testing will be certified as qualified to collect urine samples, samples or adequately trained in collection procedures. 5. Concentrations of a drug at or about above the following levels shall be considered a positive test result when using the initial immunoassay drug screening test: Initial Test Level (ng/ ml) Marijuana metabolite 100 Cocaine metabolite 300 Opiate metabolite 300* metabolites 3001 Phencyclidine 25 Amphetamines 1000 Barbiturates 300 *25ng125ng/ml m1 if immunoassay-immunoassay specific for free morphine. morphine Concentrations of a drug at or above the following levels shall be considered a positive test result when performing a confirmatory CGGC/MS test Test on a urine specimen that tested positive using a technologically different test than the initial screening method: Confirmatory Test Level method Marijuana metabolite 15* 152 Cocaine metabolite 150** Opiates: 1503 Morphine 300+ *300 Codeine 300+ *300 Phencyclidine ▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ 25 Amphetamines: Amphetamine 500 Methamphetamine 500 * 2 Delta-9-tetrahydrocannabinol-9tetrahydrocannabino1-9-carboxylic acid ** Benzoylecgonine + 25ng/ ml if immunoassay-specific for free morphine Barbiturates 3003 Benzoylecgonine 6. The laboratory selected to conduct the analysis shall be experienced and capable of quality control, documentation, chain-of-custody, technical expertise expertise, and demonstrated proficiency in urinalysis. 7. Employees having negative drug test results shall receive a memorandum stating that no illegal drugs were found. A If the employee requests such, a copy of the letter will be placed in the Employeeemployee's personnel file upon the Employee's requestfile. 8. Any employee who interferes with the testing process or breaches the confidentiality of test results testing information shall be subject to discipline.

Drug Testing Methodology. 1. A. The testing or processing phase shall consist of a two- two-step procedure: a. initial 1. Initial screening test b. confirmation test 2. Confirmation test B. The urine sample is first tested using the initial drug screening procedureprocedure of the RIA and/or EMIT type. An initial positive test result will not be considered conclusive; rather, it will be classified as "confirmation pending." ". Notification of test results to the supervisor or other departmental designee shall be held until the confirmation test results are obtained and verified by the M.R.O. 3. C. A specimen specimen-testing positive will undergo an additional confirmatory test. The confirmation procedure shall be technologically different and more sensitive than of the initial screening testgas chromatography/mass spectrometry method. 4. D. The drug screening tests selected shall be capable of identifying marijuana, cocaine and every major drug of abuse including heroin, phencyclidine, amphetamines and barbiturates. Personnel utilized for testing will be certified as qualified to collect urine samples, sample or adequately trained in collection procedures. 5. E. Concentrations of a drug at or about a minimum of the following levels shall be considered a positive test result when using the initial immunoassay drug drug- screening test: Initial Test Level (ng/ ml) Marijuana metabolite 100 Cocaine metabolite 300 Opiate metabolite metabolites 300* Phencyclidine 25 Amphetamines 1000 Barbiturates Barbiturate 300 ** 25ng/ml if immunoassay-immunoassay specific for free morphine. Concentrations of a drug at or above the following levels shall be considered a positive test result when performing a confirmatory CG/MS test on a urine specimen that tested positive using a technologically different test than the initial screening method: Confirmatory Test Level (ng/ml) Marijuana metabolite Cocaine metabolite Opiates: 15* Cocaine metabolite 150** Opiates: Morphine 300+ Codeine 300+ Phencyclidine ▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ 25 Amphetamines: Amphetamine 500 Methamphetamine 500 * Delta-9-tetrahydrocannabinol-9-*Delta- 9 tetrahydrocannabinol -9- carboxylic acid ** Benzoylecgonine + 25ng/ 25ng/ml if immunoassay-specific immunoassay -specific for free morphine Barbiturates 300 6. F. The Union will be notified of any changes in cutoff levels that are set in accordance with levels determined by the Michigan Law Enforcement Officers Training Council. G. The laboratory selected to conduct the analysis shall be experienced and capable of quality control, documentation, chain-of-chain of custody, technical expertise and demonstrated proficiency in urinalysis. 7. H. Employees having negative drug test results shall receive a memorandum stating that no illegal drugs were found. A copy of the letter will be placed in the Employeeemployee's personnel file upon the Employee's requestfile. 8. I. Any employee who interferes with the testing process or breaches the confidentiality of test results shall be subject to discipline.

Drug Testing Methodology. 1. (a) The testing or processing phase shall consist of a two- two-step procedure: a. initial 1. Initial screening test b. confirmation test 2. Confirmation test (b) The urine sample is first tested using the initial drug screening procedure. An initial positive test result will not be considered conclusive; rather, it will be classified as "“confirmation pending." ” Notification of test results to the supervisor or other departmental designee shall be held until the confirmation test results are obtained and verified by the M.R.O.obtained. 3. (c) A specimen testing positive will undergo an additional confirmatory test. The confirmation procedure shall be technologically different and more sensitive than the initial screening test. 4. (d) The drug screening tests selected shall be capable of identifying marijuana, cocaine and every major drug of abuse including heroin, amphetamines and barbiturates. Personnel utilized for testing will be certified as qualified to collect urine samples, samples or adequately trained in collection procedures. 5. (e) Concentrations of a drug at or about above the following levels shall be considered a positive test result when using the initial a FPIA immunoassay drug screening test: Initial Test Level . Amphetamines Barbiturates 500 ng/1 500 ng/1 Cocaine 300 ng/1 Opiates 300 ng/1 THC 100 ng/1 PCP 25 ng/1 Benzodiazepines 200 ng/1 Methadone 25 ng/1 (ng/ mlf) Marijuana metabolite 100 Cocaine metabolite 300 Opiate metabolite 300* Phencyclidine 25 Amphetamines 1000 Barbiturates 300 *25ng/ml if immunoassay-specific for free morphine. Concentrations of a drug at or above the following levels shall be considered a positive test result when performing a confirmatory CGGC/MS test on a urine specimen that tested positive using a technologically different test than the initial screening method: Confirmatory Test Level . Marijuana metabolite 15* Cocaine metabolite 150** Opiates: Morphine 300+ ** Codeine 300+ *** Phencyclidine ▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ 25 Amphetamines: Amphetamine 500 Methamphetamine 500 * Delta-9-Delta-9 tetrahydrocannabinol-9-carboxylic acid ** Benzoylecgonine + 25ng/ *** 25ng/ml if immunoassay-specific for free morphine Barbiturates 300 6. The laboratory selected to conduct the analysis shall be experienced and capable of quality control, documentation, chain-of-custody, technical expertise and demonstrated proficiency in urinalysis. 7. Employees having negative drug test results shall receive a memorandum stating that no illegal drugs were found. A copy of the letter will be placed in the Employee's personnel file upon the Employee's request. 8. Any employee who interferes with the testing process or breaches the confidentiality of test results shall be subject to discipline.morphine

Drug Testing Methodology. 1. The testing or processing phase shall consist of a two- step procedureof: a. initial screening test b. confirmation testtest -- if the initial screening test is positive 2. The urine sample is first tested using the initial drug screening procedure. An initial positive test result will not be considered conclusive; rather, it will be classified as "confirmation pending." Notification of test results to the supervisor or other departmental designee shall be held until the confirmation test results are obtained and verified by the M.R.O. 3. A specimen testing positive will undergo an additional confirmatory test. The confirmation procedure shall be technologically different and more sensitive than the initial screening test. 4. The drug screening tests selected shall be capable of identifying marijuana, cocaine and every major drug of abuse including heroin, phencyclidine, amphetamines and barbiturates. Personnel utilized for testing will be qualified to collect urine samples, or adequately trained in collection procedures. 5. Concentrations of a drug at or about the following levels shall be considered a positive test result when using the initial immunoassay drug screening test: Initial Test Level (ng/ ml) Marijuana metabolite 100 Cocaine metabolite metabolite. 300 Opiate metabolite 300* Phencyclidine 25 Amphetamines 1000 Barbiturates 300 *25ng/ml if immunoassay-specific for free morphine. Concentrations of a drug at or above the following levels shall be considered a positive test result when performing a confirmatory CG/MS test on a urine specimen that tested positive using a technologically different test than the initial screening method: (ng/ml) Confirmatory Test Level (ng/ml) Marijuana metabolite 15* Cocaine metabolite 150** Opiates: Morphine 300+ Codeine 300+ Phencyclidine ▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ 25 Amphetamines: Amphetamine 500 Methamphetamine 500 * Delta-9-tetrahydrocannabinol-9-carboxylic acid ** Benzoylecgonine + 25ng/ 25ng/ml if immunoassay-specific for free morphine Barbiturates 300 6. The initial and confirmatory test cutoff levels of this order are the same as that of the United States government which were published in the Federal Register, volume 54, number 230, dated December 1, 1989. These cutoff levels are subject to change by the Department of Health and Human Services as advances in technology or other considerations warrant identification of these substances at other concentrations. If these cutoff levels change in the future, the matter will be discussed with the labor associations prior to any amendment of this general order. 7. The laboratory selected to conduct the analysis shall be experienced and capable of assuring quality control, documentation, chain-of-custody, technical expertise and demonstrated proficiency in urinalysis. 78. Employees Dispatchers having negative drug test results shall receive a memorandum stating that no illegal drugs were found. A copy of the letter will be placed in the EmployeeDispatcher's personnel file upon the EmployeeDispatcher's request. 89. Any employee Dispatcher who interferes with the testing process or breaches the confidentiality of test results shall be subject to discipline.

Drug Testing Methodology. 1. The testing or processing phase shall consist of a two- two-step procedure: a. initial screening test b. confirmation test 2. The urine sample is first tested using the initial drug screening procedure. An initial positive test result will not be considered conclusive; rather, it will be classified as "“confirmation pending." ” Notification of test results to the supervisor or other departmental designee shall be held until the confirmation test results are obtained and verified by the M.R.O. 3. A specimen testing positive will undergo an additional confirmatory test. The confirmation procedure shall be technologically different and more sensitive than the initial screening test. 4. The drug screening tests selected shall be capable of identifying marijuanamarihuana, cocaine and every major drug of abuse including heroin, amphetamines and barbiturates. Personnel utilized for testing will be qualified to collect urine samples, or adequately trained in collection procedures. 5. Concentrations of a drug at or about the following levels shall be considered a positive test result when using the initial immunoassay drug screening test: Initial Test Level (ng/ ml) Marijuana Marihuana metabolite 100 Cocaine metabolite 300 Opiate metabolite 300* Phencyclidine 25 Amphetamines 1000 Barbiturates 300 *25ng25 ng/ml if immunoassay-specific for free morphine. Concentrations of a drug at or above the following levels shall be considered a positive test result when performing a confirmatory CG/MS test on a urine specimen that tested positive using a technologically different test than the initial screening method: Confirmatory Test Level Marijuana Marihuana metabolite 15* Cocaine metabolite 150** Opiates: Morphine 300+ Codeine 300+ Phencyclidine ▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ 25 Amphetamines : Amphetamine 500 Methamphetamine 500 * Delta-9*Delta -9-tetrahydrocannabinol-9-carboxylic acid ** *Benzoylecgonine + 25ng/ 25 ng/ml if immunoassay-specific for free morphine Barbiturates 300 6. The laboratory selected to conduct the analysis shall be experienced and capable of quality control, documentation, chain-of-custody, technical expertise and demonstrated proficiency in urinalysis. 7. Employees having negative drug test results shall receive a memorandum stating that no illegal drugs were found. A copy of the letter will be placed in the Employee's ’s personnel file upon the Employee's ’s request. 8. Any employee who interferes with the testing process or breaches the confidentiality of test results shall be subject to discipline.

Drug Testing Methodology. 1. A. The testing or processing phase shall consist of a two- two-step procedure: a. initial 1. Initial screening test b. confirmation test 2. Confirmation test B. The urine sample is first tested using the initial drug screening procedureprocedure of the RIA and/or EMITS type. An initial positive test result will not be considered conclusive; rather, it will be classified as "confirmation pending." ", Notification of test results to the supervisor or other departmental designee shall be held until the confirmation test results are obtained and verified by the M.R.O. 3. C. A specimen specimen-testing positive will undergo an additional confirmatory confirmation test. The confirmation procedure shall be technologically different and more sensitive than of the initial screening testgas chromatography/mass spectrometry method. 4. D. The drug screening tests selected shall be capable of identifying marijuana, cocaine and every major drug of abuse including heroin, phencyclidine, amphetamines and barbiturates. Personnel utilized for testing will be certified as qualified to collect urine samples, sample or adequately trained in collection procedures. 5. E. Concentrations of a drug at or about a minimum of the following levels shall be considered a positive test result when using the initial immunoassay drug drug- screening test: Initial Test Level (ng/ ng/ml) Marijuana metabolite 100 metabolite100 Cocaine metabolite 300 Opiate metabolite metabolites 300* Phencyclidine 25 Amphetamines 1000 Barbiturates 300 *25ng/ml if immunoassay-immunoassay specific for free morphine. Concentrations of a drug at or above the following levels shall be considered a positive test result when performing a confirmatory confirmation CG/MS test on a urine specimen that tested positive using a technologically different test than the initial screening method: Confirmatory Confirmation Test Level (nag/ml) Marijuana metabolite 15* Cocaine metabolite 150** Opiates: Morphine 300+ Codeine 300+ Phencyclidine ▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ 25 Amphetamines: Amphetamine 500 Methamphetamine 500 * Delta-9-tetrahydrocannabinol-9-*Delta - 9 tetrahydrocannabinol -9- carboxylic acid ** Benzoylecgonine + 25ng/ 25ng/ml if immunoassay-specific immunoassay -specific for free morphine Barbiturates 300 6. F. The Union will be notified of any changes in cutoff levels which are set in accordance with level determined by the Michigan Law Enforcement Officers Training Council. G. The laboratory selected to to· conduct the analysis shall be experienced and capable of quality control, control documentation, chain-of-chain of custody, technical expertise and demonstrated proficiency in urinalysis. 7. H. Employees having negative drug test results shall receive a memorandum stating that no illegal drugs were found. A copy of the letter will be placed in the Employeeemployee's personnel file upon the Employee's requestfile. 8. I. Any employee who interferes with the testing process or breaches the confidentiality of test results shall be subject to discipline.